Clare M. Williams

Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection

D. Metzger, Y. Furuya, S. Salmon, 2019, mBio.

Detrimental impact of allergic airway disease on live attenuated influenza vaccine

Y. Furuya, S. Roy, Clare M. Williams, 2021, Health science reports.

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

Wei Sun, D. Wijesundara, Y. Furuya, 2022, Clinical & translational immunology.

Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Streptococcus pneumoniae Challenge during Influenza A Infection

D. Metzger, Y. Furuya, S. Salmon, 2019, Vaccines.

A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial Infection.

Y. Furuya, S. Roy, Sean Roberts, 2020, Bio-protocol.

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity

D. Wijesundara, Y. Furuya, S. Roy, 2020, Vaccines.

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity

D. Wijesundara, J. Pardo, Y. Furuya, 2020, Vaccines.

The Interleukin-33–Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine

D. Metzger, A. McKenzie, S. Roy, 2021, Journal of virology.